T-type calcium channels: From molecule to therapeutic opportunities.

@article{Weiss2019TtypeCC,
  title={T-type calcium channels: From molecule to therapeutic opportunities.},
  author={Norbert Weiss and Gerald W. Zamponi},
  journal={The international journal of biochemistry \& cell biology},
  year={2019},
  volume={108},
  pages={
          34-39
        }
}
  • N. WeissG. Zamponi
  • Published 1 March 2019
  • Biology
  • The international journal of biochemistry & cell biology

Figures from this paper

T-Type Calcium Channels: A Mixed Blessing

The relevance of T-type calcium channels in cancer and in chemotherapy side effects is put into context, considering also the cardiotoxicity induced by new classes of antineoplastic molecules.

T-Type Channel Druggability at a Crossroads.

The potential of T-type channels as druggable targets is discussed and the strategies available for developing therapeutically efficient and specific modulators of this channel are reevaluate.

Selective inhibition of neuronal Cav3.3 T-type calcium channels by TAT-based channel peptide

The ability of a TAT-based cell penetrating peptide containing this carboxy proximal region (TAT-C3P) to modulate the activity of Cav3 channels is explored and it is shown that chronic application of Tat-C4P on tsA-201 cells expressing Cav3 channel selectively inhibits Cav3.3 channels.

Calcium Channels in the Heart: Disease States and Drugs

The type of cardiac calcium channels, their function, and disorders caused by their mutations and dysfunctions are summarized and the types of calcium channel blockers and their use in a variety of cardiac disorders are focused on.

Small Molecules as Modulators of Voltage-Gated Calcium Channels in Neurological Disorders: State of the Art and Perspectives

An overview of the role of calcium channels in neurological disorders is provided and possible strategies to generate novel therapeutics are discussed to treat such prevailing conditions of the central nervous system.

The life cycle of voltage-gated Ca2+ channels in neurons: an update on the trafficking of neuronal calcium channels

The current evidence concerning the regulatory mechanisms which underlie precise control of neuronal CaV channel trafficking are addressed and their potential as therapeutic targets are discussed.

Interactions with PDZ proteins diversify voltage‐gated calcium channel signaling

The role of PDZ proteins in controlling channel activity, regulating channel cell surface density, and influencing channel‐mediated downstream signaling events is discussed and the link between this regulatory effect and human disease is evaluated.

A potential role for T-type calcium channels in homocysteinemia-induced peripheral neuropathy.

An unrecognized signaling pathway that modulates the expression of T-type calcium channels is revealed, and may potentially contribute to the development of peripheral neuropathy associated with homocysteinemia.
...

References

SHOWING 1-10 OF 57 REFERENCES

Modulation of Cav3.2 T-type calcium channel permeability by asparagine-linked glycosylation

Data suggest that modulation of N-linked glycosylation of hCav3.2 channels may play an important physiological role, and could also support the alteration of T-type currents observed in disease states.

A Cav3.2/Stac1 molecular complex controls T-type channel expression at the plasma membrane

The existence of a Cav3.2/Stac1 molecular complex that relies on the binding of Stac1 to the amino-terminal region of the channel is reported and established as an important modulator of T-type channel expression and new insights are provided into the molecular mechanisms underlying the trafficking ofT-type channels to the plasma membrane.

Selective inhibition of neuronal Cav3.3 T-type calcium channels by TAT-based channel peptide

The ability of a TAT-based cell penetrating peptide containing this carboxy proximal region (TAT-C3P) to modulate the activity of Cav3 channels is explored and it is shown that chronic application of Tat-C4P on tsA-201 cells expressing Cav3 channel selectively inhibits Cav3.3 channels.

Glycosylation of voltage-gated calcium channels in health and disease.

Control of low-threshold exocytosis by T-type calcium channels.

Trafficking of neuronal calcium channels

An overview of the mechanisms that control the trafficking of VGCCs to and from the plasma membrane are provided, and their implication in pathophysiological conditions and their potential as therapeutic targets are discussed.

Molecular physiology of low-voltage-activated t-type calcium channels.

The goal of this review is to provide a comprehensive description of T-type currents, their distribution, regulation, pharmacology, and cloning.

Targeting voltage-gated calcium channels in neurological and psychiatric diseases

  • G. Zamponi
  • Biology, Medicine
    Nature Reviews Drug Discovery
  • 2016
An overview of calcium channels as drug targets for nervous system disorders is provided, and potential challenges and opportunities for the development of new clinically effective calcium channel inhibitors are discussed.

Recent advances in the development of T‐type calcium channel blockers for pain intervention

Recent developments in the discovery of novel classes of T‐type calcium channel blockers, and their analgesic effects in animal models of pain and in clinical trials are reviewed.

Neuronal T-type α1H Calcium Channels Induce Neuritogenesis and Expression of High-Voltage-Activated Calcium Channels in the NG108–15 Cell Line

It is demonstrated that blocking T-currents by nickel, mibefradil, or the endogenous cannabinoid anandamide prevents neuritogenesis without affecting neurite outgrowth, providing strong evidence for a dual role of T-channels in both morphological and electrical changes at early stages of neuronal differentiation.
...